Statement of Organization, Functions, and Delegations of Authority, 19711 [2013-07545]

Download as PDF Federal Register / Vol. 78, No. 63 / Tuesday, April 2, 2013 / Notices health of American women by advancing and coordinating a comprehensive women’s health agenda throughout HHS. The office fulfills its mission by advancing policy and issuing competitive contracts to an array of community, academic, and other organizations at the national and community levels. In addition, OWH’s national educational campaigns provide information about the important steps women can take to improve and maintain their health, such as NWHW. NWHW is a week-long health observance that kicks off on Mother’s Day, Sunday, May 12 and ends Saturday, May 18, 2013. NWHW seeks to educate women about improving their physical and mental health and preventing disease. More than 2,200 events were held nationwide in 2012. Week-long, daily messages encourage women to make their health a top priority and take simple steps for a longer, healthier, and happier life. For more information about NWHW, please visit https://womenshealth.gov/nwhw/. Dated: March 27, 2013. Nancy C. Lee, Deputy Assistant Secretary for Health— Women’s Health. [FR Doc. 2013–07617 Filed 4–1–13; 8:45 am] BILLING CODE 4150–33–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention srobinson on DSK4SPTVN1PROD with NOTICES Statement of Organization, Functions, and Delegations of Authority Part C (Centers for Disease Control and Prevention) of the Statement of Organization, Functions, and Delegations of Authority of the Department of Health and Human Services (45 FR 67772–76, dated October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as amended most recently at 78 FR 5812, dated January 28, 2013) is amended to reflect the reorganization of the Office for State, Tribal, Local, and Territorial Support. Section C–B, Organization and Functions, is hereby amended as follows: Delete in its entirety the title and function statements for the Knowledge Management Office (CQA5), Office of the Director (CQA). Revise the functional statement for the Public Health Law Office (CQA2), Office of the Director (CQA) as follows: After item (8), insert the following: (9) establish collaboration and coordination between clinical medicine and public VerDate Mar<15>2010 19:35 Apr 01, 2013 Jkt 229001 health to better coordinate and partner for healthier communities. Dated: March 22, 2013. Sherri A. Berger, Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2013–07582 Filed 4–1–13; 8:45 am] BILLING CODE 4160–18–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Statement of Organization, Functions, and Delegations of Authority Part C (Centers for Disease Control and Prevention) of the Statement of Organization, Functions, and Delegations of Authority of the Department of Health and Human Services (45 FR 67772–76, dated October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as amended most recently at 78 FR 5812, dated January 28, 2013) is amended to reflect the reorganization of the Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. Section C–B, Organization and Functions, is hereby amended as follows: Delete in its entirety the title and function statements for the Public Health Prevention Service Branch (CPLCC), Division of Leadership and Practice (CPLP). Dated: March 22, 2013. Sherri A. Berger, Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2013–07545 Filed 4–1–13; 8:45 am] BILLING CODE 4160–18–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2013–N–0338] Center for Devices and Radiological Health: Experiential Learning Program AGENCY: Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH or Center) is announcing an invitation for participation in its Experiential Learning Program (ELP). The ELP provides a formal training mechanism SUMMARY: PO 00000 Frm 00075 Fmt 4703 Sfmt 4703 19711 for regulatory review staff to visit research, clinical, manufacturing, and health care facilities to observe firsthand how medical devices are designed, developed, and utilized. This training is intended to provide CDRH staff with an opportunity to observe the device development life cycle and provide a better understanding of the medical devices they review, and the challenges faced throughout development, testing, manufacturing, and clinical use. The purpose of this document is to invite medical device and health care facilities to participate in this formal training program for FDA’s medical device review staff, or to contact CDRH for more information regarding the program. DATES: Submit either an electronic or written request for participation in this program by May 2, 2013. The request should include a description of your facility relative to product areas CDRH regulates. Please include the Area of Interest/Medical Device or Technology (identified in table 1or 2) that the visit will demonstrate to CDRH staff. ADDRESSES: Submit either electronic requests to https://www.regulations.gov or written requests to the Division of Dockets Management (HFA–305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville MD 20852. Identify comments with the docket number found in brackets in the heading of this document. FOR FURTHER INFORMATION CONTACT: Latonya Powell, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, Rm. 4448, Silver Spring, MD 20993–0002, 301–796–6965, FAX: 301–827–3079, Latonya.powell@fda.hhs.gov. SUPPLEMENTARY INFORMATION: I. Background CDRH launched the ELP Pilot in 2012 and will fully implement the program in 2013. The Center is responsible for ensuring the safety and effectiveness of medical devices marketed in the United States. Furthermore, CDRH assures that patients and providers have timely and continued access to safe, effective, highquality medical devices and safe radiation-emitting products. In support of this mission, the Center launched various training and development initiatives to enhance performance of its regulatory review staff and other staff involved in the premarket review process. CDRH is driven to advance regulatory science; provide industry with predictable, consistent, transparent, and efficient regulatory pathways; and assure consumer E:\FR\FM\02APN1.SGM 02APN1

Agencies

[Federal Register Volume 78, Number 63 (Tuesday, April 2, 2013)]
[Notices]
[Page 19711]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-07545]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Statement of Organization, Functions, and Delegations of 
Authority

    Part C (Centers for Disease Control and Prevention) of the 
Statement of Organization, Functions, and Delegations of Authority of 
the Department of Health and Human Services (45 FR 67772-76, dated 
October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as 
amended most recently at 78 FR 5812, dated January 28, 2013) is amended 
to reflect the reorganization of the Office of the Associate Director 
for Science, Office of the Director, Centers for Disease Control and 
Prevention.
    Section C-B, Organization and Functions, is hereby amended as 
follows:
    Delete in its entirety the title and function statements for the 
Public Health Prevention Service Branch (CPLCC), Division of Leadership 
and Practice (CPLP).

    Dated: March 22, 2013.
Sherri A. Berger,
 Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2013-07545 Filed 4-1-13; 8:45 am]
BILLING CODE 4160-18-M
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.